224 related articles for article (PubMed ID: 11263549)
1. Transplantation tolerance and mixed chimerism: at the frontier of clinical application.
Donckier V; Toungouz M; Goldman M
Transpl Int; 2001; 14(1):1-5. PubMed ID: 11263549
[TBL] [Abstract][Full Text] [Related]
2. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
3. Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance.
Remuzzi G
Am J Kidney Dis; 1998 Feb; 31(2):197-212. PubMed ID: 9469488
[TBL] [Abstract][Full Text] [Related]
4. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
5. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
[TBL] [Abstract][Full Text] [Related]
6. Donor bone marrow transplantation: chimerism and tolerance.
Delis S; Ciancio G; Burke GW; Garcia-Morales R; Miller J
Transpl Immunol; 2004; 13(2):105-15. PubMed ID: 15380541
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of tolerance induction through the transplantation of donor hematopoietic stem cells: central versus peripheral tolerance.
Wekerle T; Blaha P; Koporc Z; Bigenzahn S; Pusch M; Muehlbacher F
Transplantation; 2003 May; 75(9 Suppl):21S-25S. PubMed ID: 12819486
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific tolerance in a murine model: the result of extra-thymic T cell deletion?
van Pel M; van Breugel DW; van Wijk M; Luypen S; Vingerhoed J; Roholl PJ; Boog CJ
Transpl Immunol; 2003; 11(3-4):375-84. PubMed ID: 12967790
[TBL] [Abstract][Full Text] [Related]
9. Hurdles to the induction of tolerogenic mixed chimerism.
Pilat N; Klaus C; Schwaiger E; Wekerle T
Transplantation; 2009 May; 87(9 Suppl):S79-84. PubMed ID: 19424016
[TBL] [Abstract][Full Text] [Related]
10. Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model.
Ploemacher RE; Johnson KW; Rombouts EJ; Etienne K; Westerhof GR; Baumgart J; White-Scharf ME; Down JD
Biol Blood Marrow Transplant; 2004 Apr; 10(4):236-45. PubMed ID: 15077222
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Chimerism in organ transplantation: conflicting experiments and clinical observations.
Monaco AP
Transplantation; 2003 May; 75(9 Suppl):13S-16S. PubMed ID: 12819484
[TBL] [Abstract][Full Text] [Related]
13. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
14. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
[TBL] [Abstract][Full Text] [Related]
15. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
[TBL] [Abstract][Full Text] [Related]
16. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
Forman D; Tian C; Iacomini J
Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670
[TBL] [Abstract][Full Text] [Related]
17. Tolerance in mixed chimerism - a role for regulatory cells?
Kurtz J; Wekerle T; Sykes M
Trends Immunol; 2004 Oct; 25(10):518-23. PubMed ID: 15364053
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
[TBL] [Abstract][Full Text] [Related]
19. Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.
Guo K; Inaba M; Li M; An J; Cui W; Song C; Wang J; Cui Y; Sakaguchi Y; Tsuda M; Omae M; Ando Y; Li Q; Wang X; Feng W; Ikehara S
Transplantation; 2008 Jan; 85(1):93-101. PubMed ID: 18192918
[TBL] [Abstract][Full Text] [Related]
20. [[Chimerism and tolerance].
Nowakowska B
Postepy Hig Med Dosw; 1999; 53(6):771-83. PubMed ID: 10737038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]